Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | MMP2 | P08253 | 5/20 | 0.55 |
| ▸ | MMP9 | P14780 | 5/20 | 0.55 |
| ▸ | MMP1 | P03956 | 4/20 | 0.55 |
| ▸ | MMP13 | P45452 | 4/20 | 0.55 |
| ▸ | MMP3 | P08254 | 3/20 | 0.55 |
| ▸ | MMP7 | P09237 | 3/20 | 0.55 |
| ▸ | CA9 | Q16790 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.52 |
| ▸ | MMP8 | P22894 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28502922 | 1.00 | TSHR (0.56) | TSHRHSD17B10HTTMMP2MMP9 | |
| SCHEMBL5734780 | 1.00 | TSHR (0.56) | TSHRHSD17B10HTTMMP2MMP9 | |
| SCHEMBL3884130 | 0.86 | MMP2 (0.57) | MMP2MMP9MMP1MMP13MMP3 | |
| SCHEMBL3884127 | 0.86 | MMP2 (0.57) | MMP2MMP9MMP1MMP13MMP3 | |
| SCHEMBL698907 | 0.84 | ADAMTS4 (0.71) | TSHRHSD17B10HTTMMP2MMP9 | |
| SCHEMBL6325782 | 0.84 | ADAMTS4 (0.61) | TSHRHSD17B10HTTMMP2MMP9 | |
| SCHEMBL19000605 | 0.84 | TSHR (0.61) | TSHRHSD17B10HTTMMP2MMP9 | |
| SCHEMBL698908 | 0.84 | ADAMTS4 (0.71) | TSHRHSD17B10HTTMMP2MMP9 | |
| SCHEMBL4975578 | 0.84 | ADAMTS4 (0.71) | TSHRHSD17B10HTTMMP2MMP9 | |
| SCHEMBL28256508 | 0.84 | TSHR (0.57) | TSHRHSD17B10HTTMMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111929392-B | Method for analyzing N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof by pre-column derivatization | 吉林医药学院 | 2023-11-14 | — | — | CN | claimed |
| CN-116023320-A | 3- (N-p-toluenesulfonyl-L-alanyloxy) indole with polymorphic structure, and preparation method and application thereof | 长春百纯和成医药科技有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-115872919-A | Method for crystallizing 3- (N-p-toluenesulfonyl-L-alanyloxy) indole | 吉林医药学院 | 2023-03-31 | — | — | CN | claimed |
| CN-111929392-A | Method for pre-column derivatization analysis of N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof | 吉林医药学院 | 2020-11-13 | — | — | CN | claimed |
| CN-111929392-B | Method for analyzing N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof by pre-column derivatization | 吉林医药学院 | 2023-11-14 | — | — | CN | disclosed |
| CN-111929392-B | Method for analyzing N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof by pre-column derivatization | 吉林医药学院 | 2023-11-14 | — | — | CN | disclosed |
| CN-111929392-B | Method for analyzing N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof by pre-column derivatization | 吉林医药学院 | 2023-11-14 | — | — | CN | disclosed |
| CN-116023320-A | 3- (N-p-toluenesulfonyl-L-alanyloxy) indole with polymorphic structure, and preparation method and application thereof | 长春百纯和成医药科技有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-115872919-A | Method for crystallizing 3- (N-p-toluenesulfonyl-L-alanyloxy) indole | 吉林医药学院 | 2023-03-31 | — | — | CN | disclosed |
| CN-111929392-A | Method for pre-column derivatization analysis of N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof | 吉林医药学院 | 2020-11-13 | — | — | CN | disclosed |
| CN-111929392-A | Method for pre-column derivatization analysis of N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof | 吉林医药学院 | 2020-11-13 | — | — | CN | disclosed |
| CN-111929392-A | Method for pre-column derivatization analysis of N- (p-toluenesulfonyl) -L-alanyl chloride and enantiomer thereof | 吉林医药学院 | 2020-11-13 | — | — | CN | disclosed |
| EP-1378507-B1 | Process for producing optically active imidazole derivatives, intermediates and synthesis thereof | MITSUBISHI PHARMA CORP (JP) | 2006-08-23 | — | — | EP | disclosed |
| EP-1378507-A2 | Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same | Mitsubishi Pharma Corporation (JP) | 2004-01-07 | — | — | EP | disclosed |
| CN-1133623-C | Process for producing optically active imidazole compound, intermediate for synthesis thereof, and process for producing the same | ������ҩ��ʽ���� | 2004-01-07 | — | — | CN | disclosed |
| US-6166221-A | Production method of optically active imidazole compound, synthetic intermediate therefor and production method thereof | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2000-12-26 | — | — | US | disclosed |
| US-6066739-A | Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2000-05-23 | — | — | US | disclosed |
| CN-1251093-A | Process for producing optically active imidazole compound, intermediates for synthesizing same | YOSHITOMI PHARMACEUTICAL (JP) | 2000-04-19 | — | — | CN | disclosed |
| EP-0972768-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE IMIDAZOLE COMPOUNDS, INTERMEDIATES FOR SYNTHESIZING THE SAME, AND PROCESS FOR PRODUCING THE SAME | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2000-01-19 | — | — | EP | disclosed |
| US-3931218-A | HYPOGLYCEMIC ANTIRESERPINE, ANTIULCER, OGENIC, ANTIARRHYTHMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |